United Kingdom telehealth launch guide · 2026
Start here
Define where the service operates and which patients it will treat. A UK telehealth launch needs a clear provider-registration route, registered clinicians, safe remote assessment, and lawful health-data processing.
This guide covers the United Kingdom. Regional rules depend on the patient's location, professional role, and service. Confirm Bask availability separately.
Published by Bask Health · Editorial process
Updated
Your launch, mapped out
United Kingdom
Four nations. Separate service oversight. One accountable care model.
The 50 largest places in a combined official urban-place comparison: ONS 2022 built-up areas in England and Wales with Census 2021 populations rounded to 5; NRS Census 2022 Scottish localities with total-population attributes and statistical disclosure adjustments; and NISRA Northern Ireland settlements with exact Census 2021 counts. Greater London is included once using its rounded Census 2021 regional population; London boroughs are excluded. Population dates and boundary definitions differ, so this is an editorial coverage ranking, not a single harmonised UK census table or a 2026 population estimate. Towns qualify regardless of formal city status. Metropolitan regions and administrative council districts are not substituted for individual settlements.
The essentials
Start with the decisions that shape your legal structure and clinical workflow.
| Launch decision | United Kingdom |
|---|---|
| England | CQC regulates covered online primary care providers delivering regulated activities in England. |
| Wales | HIW identifies remote independent medical agencies based in Wales among services requiring registration. |
| Scotland | Assess independent healthcare registration with Healthcare Improvement Scotland. |
| Northern Ireland | Use RQIA registration guidance for the relevant independent service. |
| Doctors | Check GMC registration, a licence to practise, restrictions, and appropriate indemnity. |
| Prescriptions | Remote assessment must supply enough information for safe prescribing and aftercare. |
| Health data | Identify a UK GDPR Article 6 basis and an Article 9 condition for special-category processing. |
| Commercial launch | Company formation, clinical service registration, and pharmacy arrangements are separate decisions. |
Summary only, not legal advice. Confirm the requirements for your business with United Kingdom counsel.
These references support the discussion in each step. Operational suggestions are separate from legal requirements.
| Decision and full explanation | References used in this step |
|---|---|
| Set the provider identity and registration scope | |
| Apply the correct nation’s service framework | |
| Confirm the clinical team and decision authority | |
| Make remote assessment clinically adequate | |
| Agree pharmacy and medicine safeguards | |
| Document the lawful use of health data | |
| Make payment terms and care boundaries explicit | |
| Test the registered service as one system |
Local planning
A UK telehealth company needs more than an online consultation flow. The operating model joins a legal provider, regulated professionals, prescription services, and patients who may already have NHS or private care relationships. Describe each party's role before selecting software.
The four UK nations do not share one provider-registration system. CQC's online-primary-care guidance concerns England. Wales, Scotland, and Northern Ireland have their own service regulators. Professional registration and provider registration answer different questions, so a doctor's registration alone does not settle the company's position.
Choose an initial service boundary. Identify where the provider is based, where professionals work, the activities supplied, and which patients may use them. Ask the relevant regulator to resolve uncertain registration scope before accepting clinical appointments. Avoid presenting the CQC badge as a UK-wide operating passport.
Decide how your service will communicate with existing care. A medicine review, test result, or new diagnosis may matter to another clinician. Consent, records access, and follow-up ownership should form part of the product requirements, not an afterthought in the support queue.
The commercial opportunity also needs direct research. Interview the intended patients about appointment access, cost, privacy, and continuity. A convenient interface does not prove that remote assessment is suitable for the condition or that a paid service fits the patient's care pathway.
Sources: CQC: definition of online primary care services, HIW: services that need registration, GOV.UK: independent healthcare registration in Scotland, RQIA: registration guidance.
Step by step
Build the company and clinical service together. Each step should produce evidence that the registered provider can actually operate the proposed patient journey.
Write a service description covering assessment, diagnosis, treatment, prescribing, and any tests. State which legal person carries responsibility for the care. Distinguish that provider from a technology supplier, marketing agency, and dispensing pharmacy.
Companies House registration establishes a company. It does not authorize a regulated healthcare activity. Review the entity, directors, ownership, and tax obligations with advisers, then assess the clinical service under the applicable national framework.
For England, CQC defines online primary care as covered services delivered through online means. Registration scope depends on the activities and operating arrangements. Ask the regulator when a remote or cross-border structure creates uncertainty.
Keep a written responsibility map beside the incorporation documents. Name the owner of clinical governance, complaints, prescribing policy, safeguarding, and records. If contracts describe a different provider from the website, correct the mismatch before launch. Patients should be able to identify who is treating them and how to raise concerns.
Sources: GOV.UK: set up a limited company, CQC: definition of online primary care services.
Assess England, Wales, Scotland, and Northern Ireland separately rather than repeating one registration answer. Include the provider's base and service configuration in that assessment. Patient geography alone may not answer every scope question.
HIW lists independent medical agencies among Welsh services needing registration, including certain remote private medical services based in Wales. Scotland's independent-healthcare route is administered by Healthcare Improvement Scotland. RQIA publishes registration guidance for independent services in Northern Ireland.
For an English online-primary-care application, check the current CQC document list. Its guidance introduced additional application documents from June 22, 2026. Use the live requirements rather than an old application checklist or another provider's submission.
Build the project schedule around actual readiness evidence and regulator decisions. Do not promise a registration date based on company formation alone. When the offer changes, reassess whether the existing registration covers the added activity, location, management arrangement, or patient group.
Sources: HIW: services that need registration, GOV.UK: independent healthcare registration in Scotland, RQIA: registration guidance, CQC: supporting documents for online primary care.
Confirm the availability and integrations your United Kingdom service would need.
Check each doctor's GMC record, licence to practise, and any conditions relevant to the proposed duties. Check other professionals with their own regulator. Confirm that the indemnity arrangement covers remote work and the planned service.
The GMC's remote-care guidance applies professional standards to telephone, video, and online encounters. Commercial targets must leave room for a clinician to decline remote treatment, seek more information, or arrange another route. Record that authority in employment and contractor arrangements.
Create an induction using actual product screens. Ask clinicians to identify missing information, misleading prompts, and actions that could be mistaken for approval. Give them a route to raise concerns about unsafe system design.
Set supervision, absence cover, and escalation responsibilities before booking patients. Test what happens when the expected prescriber is unavailable or a restriction changes. A full calendar is not evidence of adequate coverage if urgent questions and abnormal results have no accountable clinician.
Sources: GMC: remote prescribing principles, GMC: professional standards in remote consultations.
Start with the information needed to decide whether the patient can safely receive the service. The GMC says a prescriber needs adequate knowledge of the patient's health and confidence that treatment meets their needs. An attractive intake questionnaire does not establish either condition.
Define identity checks, dialogue, consent, relevant records, observations, and any examination or testing. Match the communication method to that assessment. Explain what the patient should do if the clinician cannot reach a safe decision remotely.
Review requests to withhold information from a usual prescriber with the clinical team. The GMC highlights circumstances where missing information or limited sharing can make prescribing unsafe. Build an explicit escalation path rather than silently continuing the purchase flow.
Include safeguarding, capacity, accessibility, and emergency-location checks in the workflow. Rehearse a patient who disconnects while describing a serious symptom. The correct response may be local urgent help, not another automated reminder to finish a form.
Sources: GMC: deciding whether it is safe to prescribe, GMC: remote prescribing principles.
Identify the pharmacy that will dispense, its regulator, and the contracts connecting it to the prescriber. Great Britain and Northern Ireland have different pharmacy regulators. Confirm the relevant register and standards for the actual premises and service.
Online pharmacy safeguards deserve a separate review for higher-risk medicines. GPhC's 2025 materials describe stronger checks for online supply, including independent verification of weight-related information for weight-management medicines. Do not rely only on a customer's chosen answer or uploaded claim.
Ask the pharmacy to demonstrate prescription verification, clarification, refusal, cancellation, and delivery exception handling. Keep prescribing decisions separate from inventory or advertising incentives. The product must support an outcome where medicine is not supplied.
Show patients who prescribes and who dispenses. Explain fees, alternatives, and support contacts accurately. If the pharmacy relationship changes, assess the clinical and data handoffs again instead of substituting a new logo into the same checkout experience.
Sources: GPhC: July 2025 council papers on online pharmacy safeguards, GMC: deciding whether it is safe to prescribe.
Health information is special-category personal data under the UK GDPR framework. The ICO explains that an organization needs an Article 6 lawful basis and an Article 9 condition. Identify the conditions for each purpose rather than treating one consent checkbox as a complete privacy design.
Map the controller and processor roles of the provider, software company, pharmacy, support team, and other vendors. Describe records access, security, retention, patient rights, and international transfers. Evaluate whether the planned processing requires a data protection impact assessment.
Keep patient records separate from acquisition analytics. A page about treatment, an intake answer, and a prescription decision can reveal sensitive information. Review tracking technology before adding it to clinical pages or sharing events with advertising services.
Test a subject-access request, staff departure, vendor outage, and suspected data incident with synthetic records. The written policy should match the permissions and export behavior in the working system. Assign someone who can make decisions when an incident spans several partners.
Sources: ICO: special category data requirements.
State whether the offer is private care, an NHS-commissioned pathway, or another contractual arrangement. Do not imply NHS affiliation or guaranteed access without an actual basis. Keep the provider identity and complaint route visible at the point of purchase.
Explain consultation charges, medicine costs, tests, subscriptions, cancellation, and situations where the service cannot proceed. Have advisers review the consumer terms and the clinical lead review the patient explanation. A payment confirmation should never look like a prescription approval.
Model operational costs for declined treatment, repeat contact, record requests, and in-person referrals. If pricing assumes every consultation ends in a sale, revisit the offer. The care model needs to remain viable when clinicians act independently.
Assess advertising claims against the final service. Avoid promised outcomes, misleading eligibility language, or product-first messaging that undermines assessment. The same boundaries should appear in staff scripts, booking screens, and follow-up communications. Keep a versioned record of what was reviewed before campaigns start.
Sources: GMC: remote prescribing principles, GMC: deciding whether it is safe to prescribe.
Run a rehearsal that follows a patient from discovery through assessment, possible prescribing, payment, follow-up, and complaint handling. Use safe fixtures. Include inaccessible technology, incomplete records, a declined prescription, and a patient outside the service boundary.
Check that the escalation route works outside ordinary appointment hours. The clinical lead should be able to find unresolved tests, missed contacts, and pharmacy questions without searching separate inboxes. Track these outcomes during an initial controlled launch.
Prepare evidence for the relevant regulator and keep it consistent with the live service. Policies copied from an unrelated clinic will not demonstrate how this provider operates. Update the record whenever the service scope, management, clinical team, or supplier arrangement changes.
Discuss international requirements with Bask using this evidence. Confirm UK availability, hosting, integrations, prescription support, and commercial terms directly. No part of this guide represents CQC approval, another regulator's approval, or a commitment that Bask can supply the proposed UK clinical service.
Sources: CQC: supporting documents for online primary care, GMC: professional standards in remote consultations.
What to launch
Select a clinical offer only after the provider, professional, pharmacy, and data requirements are clear. These examples identify decisions to test.
CQC's definition helps founders assess covered online primary-care services in England. A UK-wide marketing page should not obscure the other nations' registration frameworks. Start with a defined set of presentations, an accountable provider, and an in-person escalation arrangement. Check that records reach the right care team after the appointment.
Medication access needs a clinically sound assessment and the pharmacy safeguards relevant to the product. GPhC's strengthened online guidance includes independent verification of weight-related information. Plan how that evidence is obtained, reviewed, and updated. A checkout attestation should not stand in for the prescriber's assessment or required monitoring.
Sources: GPhC: July 2025 council papers on online pharmacy safeguards.
Repeat treatment can create an ongoing care relationship even when contact is brief. Check records, changes in health, monitoring, and coordination with the usual prescriber. The GMC's prescribing guidance supports a decision to seek further information or decline a remote prescription. Make that decision operationally possible without pressuring the clinician.
Built for telehealth
Bring your UK service scope and regulator requirements to Bask. Evaluate the software against those needs and confirm country availability before signing provider or pharmacy agreements.
Built with Bask
Customer experiences supplied with permission. These are individual testimonials, not independently audited results or evidence of Bask availability in another country.
“Partnering with Bask Health transformed how we operate at Good Life Meds. Their end-to-end, fully integrated technology stack empowered us to scale rapidly while improving both patient experience and operational efficiency. From seamless patient journeys to robust integrations with our medical groups and pharmacy partners, Bask Health has consistently delivered best-in-class solutions. Their commitment to continuous innovation has helped us evolve from a startup into an industry-leading brand.“
No. CQC regulates covered services in England. Wales, Scotland, and Northern Ireland have separate service regulators. The provider location, activities, and operating arrangements affect the analysis. Assess each relevant framework rather than assuming one registration authorizes every UK service.
Only when the responsible professional can meet the applicable assessment and prescribing standards. The GMC requires adequate knowledge of the patient and a suitable consultation method. Missing records, examination needs, or insufficient dialogue can prevent a safe remote prescription.
No. It establishes the company, while clinical service registration and professional authority are separate questions. Identify the legal provider and its activities, then assess the relevant healthcare regulator. Do not accept clinical bookings on the assumption that incorporation settles those requirements.
No. Identify an Article 6 lawful basis and an Article 9 condition for the relevant processing under the UK GDPR framework. Clinical care, support, analytics, and advertising have different purposes. Assess each data flow and the appropriate safeguards instead of relying on a universal checkbox.
No. This guide is a planning resource and does not confirm UK product availability, clinical coverage, pharmacy access, or regulatory approval. Discuss the exact service and integrations with Bask. Your provider and advisers remain responsible for the clinical and regulatory operating model.
Compare state, city, and country guides. Check the jurisdiction that applies to the patient, clinician, and business before you expand.
Bask Health publishes this AI-assisted guide from the references below. It has not received independent legal or clinical approval. Read the research method and correction policy.
Your next step
Bring your treatment plan, target patient group, and launch dependencies. Discuss the software and integrations your service needs.